Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 1.400
0.00 (0.00%)
Sep 18, 2026, 4:18 PM GMT
AIM:CNSL Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 6.98 | 8.33 | 9.77 | 7.55 | 8.54 | |
Revenue Growth | -16.27% | -14.77% | 29.53% | -11.63% | 25.28% |
Cost of Revenue | 2.25 | 2.89 | 3.73 | 4 | 3.44 |
Gross Profit | 4.73 | 5.44 | 6.05 | 3.55 | 5.1 |
Selling, General & Admin | 5.78 | 6.12 | 6.67 | 6.29 | 5.69 |
Other Operating Expenses | -0.14 | -0.28 | -0.08 | -0.03 | - |
Operating Expenses | 5.94 | 5.84 | 6.58 | 6.26 | 5.69 |
Operating Income | -1.21 | -0.4 | -0.54 | -2.72 | -0.59 |
Interest Expense | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 |
Interest & Investment Income | 0.07 | 0.15 | 0.05 | - | - |
EBT Excluding Unusual Items | -1.15 | -0.27 | -0.51 | -2.73 | -0.61 |
Impairment of Goodwill | -3.02 | - | - | - | - |
Other Unusual Items | -0.25 | 1.83 | -0.24 | -0.52 | -0.34 |
Pretax Income | -4.42 | 1.57 | -0.75 | -3.25 | -0.95 |
Income Tax Expense | 1.41 | - | -0.42 | -0.08 | 0.46 |
Earnings From Continuing Operations | -5.83 | 1.57 | -0.33 | -3.17 | -1.41 |
Earnings From Discontinued Operations | - | - | - | -0.69 | -9.92 |
Net Income | -5.83 | 1.57 | -0.33 | -3.86 | -11.33 |
Net Income to Common | -5.83 | 1.57 | -0.33 | -3.86 | -11.33 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 238 | 238 | 238 | 231 | 183 |
Shares Outstanding (Diluted) | 238 | 238 | 238 | 232 | 187 |
Shares Change | -0.13% | 0.07% | 2.70% | 23.98% | 5.59% |
EPS (Basic) | -0.02 | 0.01 | -0.00 | -0.02 | -0.06 |
EPS (Diluted) | -0.02 | 0.01 | -0.00 | -0.02 | -0.06 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1.45 | -0.28 | 0.56 | -3.18 | -4.2 |
Free Cash Flow Per Share | -0.01 | -0.00 | 0.00 | -0.01 | -0.02 |
Gross Margin | 67.80% | 65.32% | 61.86% | 46.98% | 59.75% |
Operating Margin | -17.35% | -4.74% | -5.47% | -35.98% | -6.93% |
Profit Margin | -83.53% | 18.80% | -3.36% | -51.15% | -132.72% |
Free Cash Flow Margin | -20.83% | -3.38% | 5.72% | -42.10% | -49.15% |
EBITDA | -0.99 | -0.1 | -0.2 | -2.39 | -0.05 |
EBITDA Margin | -14.18% | -1.14% | -2.05% | -31.63% | -0.61% |
D&A For EBITDA | 0.22 | 0.3 | 0.34 | 0.33 | 0.54 |
EBIT | -1.21 | -0.4 | -0.54 | -2.72 | -0.59 |
EBIT Margin | -17.35% | -4.74% | -5.47% | -35.98% | -6.93% |